{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:55:00Z","timestamp":1773975300303,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12011-023-03670-8","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T10:02:07Z","timestamp":1682157727000},"page":"246-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complexation of the Antihypertensive Drug Olmesartan with Zn: In Vivo Antihypertensive and Cardiac Effects"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-0030","authenticated-orcid":false,"given":"Andr\u00e9s G.","family":"Restrepo Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-6979","authenticated-orcid":false,"given":"Valeria R.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge O.","family":"Velez Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-4668","authenticated-orcid":false,"given":"Enrique L.","family":"Portiansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-2885","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"De Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-5170","authenticated-orcid":false,"given":"Evelina G.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-5873","authenticated-orcid":false,"given":"Patricia A.M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/hypertensionaha.121.18192","volume":"79","author":"A Al-Makki","year":"2022","unstructured":"Al-Makki A, DiPette D, Whelton PK et al (2022) Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary. Hypertension 79:293\u2013301. https:\/\/doi.org\/10.1161\/hypertensionaha.121.18192","journal-title":"Hypertension"},{"key":"3670_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MNH.0000000000000373","volume":"27","author":"MC van Haaster","year":"2018","unstructured":"van Haaster MC, McDonough AA, Gurley SB (2018) Blood pressure regulation by the angiotensin type 1 receptor in the proximal tubule. Curr Opin Nephrol Hypertens 27:1\u20137. https:\/\/doi.org\/10.1097\/MNH.0000000000000373","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3670_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/24748706.2021.1944708","volume":"5","author":"BA Carabello","year":"2021","unstructured":"Carabello BA (2021) The pathophysiology of afterload mismatch and ventricular hypertrophy. Structural Heart 5:446\u2013456. https:\/\/doi.org\/10.1080\/24748706.2021.1944708","journal-title":"Structural Heart"},{"key":"3670_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.37349\/emed.2021.00054","volume":"2","author":"SK Bhullar","year":"2021","unstructured":"Bhullar SK, Shah AK, Dhalla NS (2021) Role of angiotensin II in the development of subcellular remodeling in heart failure. Exp Ther Med 2:352\u2013371. https:\/\/doi.org\/10.37349\/emed.2021.00054","journal-title":"Exp Ther Med"},{"key":"3670_CR5","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.scp.2021.100409","volume":"20","author":"A Ladhari","year":"2021","unstructured":"Ladhari A, la Mura G, di Marino C et al (2021) Sartans: what they are for, how they degrade, where they are found and how they transform. Sustain Chem Pharm 20:100409. https:\/\/doi.org\/10.1016\/j.scp.2021.100409","journal-title":"Sustain Chem Pharm"},{"key":"3670_CR6","doi-asserted-by":"publisher","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","volume":"290","author":"H Zhang","year":"2015","unstructured":"Zhang H, Unal H, Desnoyer R et al (2015) Structural basis for ligand recognition and functional selectivity at angiotensin receptor. J Biol Chem 290:29127\u201329139. https:\/\/doi.org\/10.1074\/jbc.M115.689000","journal-title":"J Biol Chem"},{"key":"3670_CR7","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s12011-020-02462-8","volume":"199","author":"P Sharma","year":"2021","unstructured":"Sharma P, Reddy PK, Kumar B (2021) Trace element zinc, a nature\u2019s gift to fight unprecedented global pandemic COVID-19. Biol Trace Elem Res 199:3213\u20133221. https:\/\/doi.org\/10.1007\/s12011-020-02462-8","journal-title":"Biol Trace Elem Res"},{"key":"3670_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00775-014-1139-0","volume":"19","author":"K Jurowski","year":"2014","unstructured":"Jurowski K, Szewczyk B, Nowak G, Piekoszewski W (2014) Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. J Biol Inorg Chem 19:1069\u20131079. https:\/\/doi.org\/10.1007\/s00775-014-1139-0","journal-title":"J Biol Inorg Chem"},{"key":"3670_CR9","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s12011-021-03011-7","volume":"200","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Xue Y, Fu Y et al (2022) Zinc Deficiency aggravates oxidative stress leading to inflammation and fibrosis in lung of mice. Biol Trace Elem Res 200:4045\u20134057. https:\/\/doi.org\/10.1007\/s12011-021-03011-7","journal-title":"Biol Trace Elem Res"},{"key":"3670_CR10","doi-asserted-by":"publisher","first-page":"214088","DOI":"10.1016\/j.ccr.2021.214088","volume":"445","author":"M Pellei","year":"2021","unstructured":"Pellei M, del Bello F, Porchia M, Santini C (2021) Zinc coordination complexes as anticancer agents. Coord Chem Rev 445:214088. https:\/\/doi.org\/10.1016\/j.ccr.2021.214088","journal-title":"Coord Chem Rev"},{"key":"3670_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4155\/fmc-2020-0093","volume":"13","author":"VR Mart\u00ednez","year":"2021","unstructured":"Mart\u00ednez VR, Aguirre MV, Todaro JS et al (2021) Zinc complexation improves angiotensin II receptor type 1 blockade and in vivo antihypertensive activity of telmisartan. Future Med Chem 13:13\u201323. https:\/\/doi.org\/10.4155\/fmc-2020-0093","journal-title":"Future Med Chem"},{"key":"3670_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ab.2009.10.037","volume":"397","author":"CE S\u00e4bel","year":"2010","unstructured":"S\u00e4bel CE, Neureuther JM, Siemann S (2010) A spectrophotometric method for the determination of zinc, copper, and cobalt ions in metalloproteins using Zincon. Anal Biochem 397:218\u2013226. https:\/\/doi.org\/10.1016\/j.ab.2009.10.037","journal-title":"Anal Biochem"},{"key":"3670_CR13","first-page":"241","volume-title":"Profiles of Drug Substances, Excipients and Related Methodology","author":"AA Al-Majed","year":"2017","unstructured":"Al-Majed AA, Bakheit AHH, Abdel Aziz HA, Al-Jallal AAM (2017) Olmesartan. In: Profiles of Drug Substances, Excipients and Related Methodology. Academic Press Inc., pp 241\u2013286"},{"key":"3670_CR14","doi-asserted-by":"publisher","first-page":"21346","DOI":"10.3390\/molecules201219762","volume":"20","author":"I Dams","year":"2015","unstructured":"Dams I, Ostaszewska A, Puchalska M et al (2015) Synthesis and physicochemical characterization of the process-related impurities of olmesartan medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist? Molecules 20:21346\u201321363. https:\/\/doi.org\/10.3390\/molecules201219762","journal-title":"Molecules"},{"key":"3670_CR15","doi-asserted-by":"publisher","unstructured":"Li J, Kemp BA, Howell NL et al (2019) Metabolic changes in spontaneously hypertensive rat hearts precede cardiac dysfunction and left ventricular hypertrophy. J Am Heart Assoc 8. https:\/\/doi.org\/10.1161\/JAHA.118.010926","DOI":"10.1161\/JAHA.118.010926"},{"key":"3670_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4:303\u2013306. https:\/\/doi.org\/10.4103\/0976-500X.119726","journal-title":"J Pharmacol Pharmacother"},{"key":"3670_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00380-008-1104-3","volume":"24","author":"C Fernandes-Santos","year":"2009","unstructured":"Fernandes-Santos C, de Souza ML, Mandarim-de-Lacerda CA (2009) Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats. Heart Vessels 24:219\u2013227. https:\/\/doi.org\/10.1007\/s00380-008-1104-3","journal-title":"Heart Vessels"},{"key":"3670_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1440-1681.1992.tb00472.x","volume":"19","author":"EF Jones","year":"1992","unstructured":"Jones EF, Harrap SB, Calafiore P, Tonkin AM (1992) Development and validation of echocardiography methods for estimating left ventricular mass in rats. Clin Exp Pharmacol Physiol 19:361\u2013364. https:\/\/doi.org\/10.1111\/j.1440-1681.1992.tb00472.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3670_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613\u2013618. https:\/\/doi.org\/10.1161\/01.CIR.55.4.613","journal-title":"Circulation"},{"key":"3670_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5114\/ceh.2020.99513","volume":"6","author":"K Mousavi","year":"2020","unstructured":"Mousavi K, Niknahad H, Ghalamfarsa A et al (2020) Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms. Clin Exp Hepatol 6:207\u2013219. https:\/\/doi.org\/10.5114\/ceh.2020.99513","journal-title":"Clin Exp Hepatol"},{"key":"3670_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","volume":"74","author":"PJ Hissin","year":"1976","unstructured":"Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214\u2013226. https:\/\/doi.org\/10.1016\/0003-2697(76)90326-2","journal-title":"Anal Biochem"},{"key":"3670_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"key":"3670_CR23","unstructured":"National Center for Biotechnology Information (2022) PubChem Compound Summary for CID 158781, Olmesartan. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Olmesartan. Accessed 18 Sept 2022"},{"key":"3670_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/jm950450f","volume":"39","author":"H Yanagisawa","year":"1996","unstructured":"Yanagisawa H, Amemiya Y, Kanazaki T et al (1996) Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure\u2212activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds. J Med Chem 39:323\u2013338. https:\/\/doi.org\/10.1021\/jm950450f","journal-title":"J Med Chem"},{"key":"3670_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0010-8545(00)80455-5","volume":"33","author":"G Deacon","year":"1980","unstructured":"Deacon G (1980) Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord Chem Rev 33:227\u2013250. https:\/\/doi.org\/10.1016\/S0010-8545(00)80455-5","journal-title":"Coord Chem Rev"},{"key":"3670_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/jrs.2282","volume":"40","author":"CA Franca","year":"2009","unstructured":"Franca CA, Etcheverry SB, Pis Diez R, Williams PAM (2009) Irbesartan: FTIR and Raman spectra. Density functional study on vibrational and NMR spectra. J Raman Spectrosc 40:1296\u20131300. https:\/\/doi.org\/10.1002\/jrs.2282","journal-title":"J Raman Spectrosc"},{"key":"3670_CR27","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1590\/S0103-50532013005000005","volume":"23","author":"B Akhlaghinia","year":"2012","unstructured":"Akhlaghinia B, Rezazadeh S (2012) A novel approach for the synthesis of 5-substituted-1H-tetrazoles. J Braz Chem Soc 23:2197\u20132203. https:\/\/doi.org\/10.1590\/S0103-50532013005000005","journal-title":"J Braz Chem Soc"},{"key":"3670_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10965-014-0526-0","volume":"21","author":"D Sinirlioglu","year":"2014","unstructured":"Sinirlioglu D, Muftuoglu AE, Bozkurt A (2014) Investigation of proton conductivity of inorganic\u2013organic hybrid membranes based on boronic acid and tetrazole. J Polym Res 21:526. https:\/\/doi.org\/10.1007\/s10965-014-0526-0","journal-title":"J Polym Res"},{"key":"3670_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/0929867323666151117122116","volume":"23","author":"T Kellici","year":"2015","unstructured":"Kellici T, Ntountaniotis D, Kritsi E et al (2015) Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angiotensin II type 1 G-protein coupled receptor. Curr Med Chem 23:36\u201359. https:\/\/doi.org\/10.2174\/0929867323666151117122116","journal-title":"Curr Med Chem"},{"key":"3670_CR30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","volume":"161","author":"H Zhang","year":"2015","unstructured":"Zhang H, Unal H, Gati C et al (2015) Structure of the angiotensin receptor revealed by serial femtosecond crystallography. Cell 161:833\u2013844. https:\/\/doi.org\/10.1016\/j.cell.2015.04.011","journal-title":"Cell"},{"key":"3670_CR31","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1021\/ja01176a030","volume":"71","author":"HA Benesi","year":"1949","unstructured":"Benesi HA, Hildebrand JH (1949) A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J Am Chem Soc 71:2703\u20132707. https:\/\/doi.org\/10.1021\/ja01176a030","journal-title":"J Am Chem Soc"},{"key":"3670_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jtcvs.2018.01.097","volume":"156","author":"A Uchinaka","year":"2018","unstructured":"Uchinaka A, Yoshida M, Tanaka K et al (2018) Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution. J Thorac Cardiovasc Surg 156:217\u2013226.e3. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.01.097","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3670_CR33","doi-asserted-by":"publisher","first-page":"e2160","DOI":"10.1097\/MD.0000000000002160","volume":"94","author":"C-Y Wu","year":"2015","unstructured":"Wu C-Y, Hu H-Y, Chou Y-J et al (2015) High blood pressure and all-cause and cardiovascular disease mortalities in community-dwelling older adults. Medicine 94:e2160. https:\/\/doi.org\/10.1097\/MD.0000000000002160","journal-title":"Medicine"},{"key":"3670_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/15376516.2012.666650","volume":"22","author":"SK Maulik","year":"2012","unstructured":"Maulik SK, Kumar S (2012) Oxidative stress and cardiac hypertrophy: a review. Toxicol Mech Methods 22:359\u2013366. https:\/\/doi.org\/10.3109\/15376516.2012.666650","journal-title":"Toxicol Mech Methods"},{"key":"3670_CR35","doi-asserted-by":"publisher","first-page":"H919","DOI":"10.1152\/ajpheart.00131.2017","volume":"313","author":"MP Blaustein","year":"2017","unstructured":"Blaustein MP (2017) How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na + pumps are crucial. Am J Physiol Heart Circ Physiol 313:H919\u2013H930. https:\/\/doi.org\/10.1152\/ajpheart.00131.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3670_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T (2016) Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 97:245\u2013262. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.06.001","journal-title":"J Mol Cell Cardiol"},{"key":"3670_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.7150\/ijbs.7.154","volume":"7","author":"V Sukumaran","year":"2011","unstructured":"Sukumaran V, Watanabe K, Veeraveedu PT et al (2011) Olmesartan, an AT 1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis. Int J Biol Sci 7:154\u2013167. https:\/\/doi.org\/10.7150\/ijbs.7.154","journal-title":"Int J Biol Sci"},{"key":"3670_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191\u2013227. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.04.005","journal-title":"Pharmacol Ther"},{"key":"3670_CR39","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3892\/mmr_00000164","volume":"2","author":"N Tomita","year":"2009","unstructured":"Tomita N, Yamasaki K, Osako MK, Komai N, Shimosato T, Morishita R (2009) Combination therapy based on the angiotensin receptor blocker olmesartan for vascular protection in spontaneously hypertensive rats. Mol Med Rep 2:733\u2013738. https:\/\/doi.org\/10.3892\/mmr_00000164","journal-title":"Mol Med Rep"},{"key":"3670_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000323535","volume":"34","author":"H Nagasu","year":"2011","unstructured":"Nagasu H, Satoh M, Yorimitsu D et al (2011) Comparison of combination therapy of olmesartan plus azelnidipine or hydrochlorothiazide on renal and vascular damage in SHR\/NDmcr-cp rats. Kidney Blood Press Res 34:87\u201396. https:\/\/doi.org\/10.1159\/000323535","journal-title":"Kidney Blood Press Res"},{"key":"3670_CR41","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00204-020-02702-9","volume":"94","author":"CT Chasapis","year":"2020","unstructured":"Chasapis CT, Ntoupa P-SA, Spiliopoulou CA, Stefanidou ME (2020) Recent aspects of the effects of zinc on human health. Arch Toxicol 94:1443\u20131460. https:\/\/doi.org\/10.1007\/s00204-020-02702-9","journal-title":"Arch Toxicol"},{"key":"3670_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/156802612799078874","volume":"12","author":"Y Yoshikawa","year":"2012","unstructured":"Yoshikawa Y, Yasui H (2012) Zinc Complexes developed as metallopharmaceutics for treating diabetes mellitus based on the bio-medicinal inorganic chemistry. Curr Top Med Chem 12:210\u2013218. https:\/\/doi.org\/10.2174\/156802612799078874","journal-title":"Curr Top Med Chem"},{"key":"3670_CR43","doi-asserted-by":"publisher","first-page":"175654","DOI":"10.1016\/j.ejphar.2023.175654","volume":"946","author":"VR Martinez","year":"2023","unstructured":"Martinez VR, Martins Lima A, Stergiopulos N et al (2023) Effect of the structural modification of Candesartan with Zinc on hypertension and left ventricular hypertrophy. Eur J Pharmacol 946:175654. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175654","journal-title":"Eur J Pharmacol"},{"key":"3670_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.CIR.91.1.161","volume":"91","author":"CH Conrad","year":"1995","unstructured":"Conrad CH, Brooks WW, Hayes JA et al (1995) Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 91:161\u2013170. https:\/\/doi.org\/10.1161\/01.CIR.91.1.161","journal-title":"Circulation"},{"key":"3670_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0008-6363(00)00037-7","volume":"46","author":"C Kupfahl","year":"2000","unstructured":"Kupfahl C (2000) Angiotensin II directly increases transforming growth factor \u03b21 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res 46:463\u2013475. https:\/\/doi.org\/10.1016\/S0008-6363(00)00037-7","journal-title":"Cardiovasc Res"},{"key":"3670_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","volume":"118","author":"R Khan","year":"2006","unstructured":"Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta1 in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10\u201324. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02336.x","journal-title":"Immunology"},{"key":"3670_CR47","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.3892\/mmr.2018.9448","volume":"18","author":"H Tian","year":"2018","unstructured":"Tian H, Yu D, Hu Y et al (2018) Angiotensin II upregulates cyclophilin A by enhancing ROS production in rat cardiomyocytes. Mol Med Rep 18:4349\u20134355. https:\/\/doi.org\/10.3892\/mmr.2018.9448","journal-title":"Mol Med Rep"},{"key":"3670_CR48","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"M Seddon","year":"2007","unstructured":"Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93:903\u2013907. https:\/\/doi.org\/10.1136\/hrt.2005.068270","journal-title":"Heart"},{"key":"3670_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1291\/hypres.28.67","volume":"28","author":"M Tanaka","year":"2005","unstructured":"Tanaka M, Umemoto S, Kawahara S et al (2005) Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu\/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 28:67\u201377. https:\/\/doi.org\/10.1291\/hypres.28.67","journal-title":"Hypertens Res"},{"key":"3670_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5028181","volume":"2019","author":"VP Bajic","year":"2019","unstructured":"Bajic VP, van Neste C, Obradovic M et al (2019) Glutathione \u201credox homeostasis\u201d and its relation to cardiovascular disease. Oxid Med Cell Longev 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/5028181","journal-title":"Oxid Med Cell Longev"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-023-03670-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-023-03670-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-023-03670-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T06:21:19Z","timestamp":1704262879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-023-03670-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1007\/s12011-023-03670-8","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,22]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}